Biotech

All Articles

Relay loses 10% of personnel after earlier discharges in July

.Preciseness medication biotech Relay Therapeutics is shedding around 10% of its workforce in effort...

Pentixapharm credit ratings $22M IPO to loan radiopharma trials

.Pentixapharm has introduced nearly 20 thousand euros ($ 22 million) from an IPO, with the German bi...

Lundbeck faucets Charles Waterway for AI-enabled neuro drug discovery

.Lundbeck has actually tapped Charles Waterway Laboratories' artificial intelligence capacities to a...

Big pharma, biotech 'won't always be cooperative' in AI: S&ampP

.Large Pharma is committing heavily in AI to slash development timelines and foster advancement. But...

I &amp I biotech Triveni elevates $115M for preclinical antitoxins

.Triveni Biography has roped in $115 thousand in set B funds to accelerate preclinical antibody prog...

IGM rotates coming from cancer to autoimmune, agitating C-suite

.IGM Biosciences ended in 2013 laying off staff as well as simplifying its cancer pipeline. Currentl...

Shattuck axes CD47 program over unstable efficiency records, gives up 40% of staff as well as drops Ono deal

.Shattuck Labs has knocked an additional nail into the coffin of CD47. After finding a "small" resul...

BioMarin goes Camping outdoors, striking RNA deal with biotech

.BioMarin is adding kindling to the R&ampD fire, attacking a suit with CAMP4 Therapies for liberties...

Cash- strapped Gritstone starts hunt for strategic options as cancer vaccination data underwhelm

.Gritstone bio has introduced bankers to look into "prospective value-maximizing methods" after its ...

Kailera launches along with $400M series A, 4 Mandarin excessive weight medications

.Kailera Therapeutics has actually introduced in to the more and more jampacked being overweight roo...